A Randomized, Double-blind, Multicenter,Placebo-controlled Phase 3 Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumabin Adults with Myasthenia Gravis

Project: Research project

Project Details

Description

A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults with Myasthenia Gravis
StatusActive
Effective start/end date1/1/2112/31/24

Funding

  • MEDPACE, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.